NCT03878485: Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine

NCT03878485
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older ¬† (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: 
Exclusions: Patients with a past history of radiotherapy within the projected treatment field; Patients with symptomatic spinal cord compression
https://ClinicalTrials.gov/show/NCT03878485

Comments are closed.

Up ↑